Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,268,540 papers from all fields of science
Search
Sign In
Create Free Account
aphidicolin glycinate
Known as:
AphiG
, aphidicolin-17-glycinate
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Aphidicolin
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Индекс ВИЗГ – новый мультипараметрический показатель для рака предстательной железы
Н. С. Сергеева
,
Т. Е. Скачкова
,
+5 authors
Андрей Дмитриевич Каприн
2016
Corpus ID: 79751771
Serum of 336 patients with primary prostate cancer (PC) with baseline total prostate-specific antigen level (totPSA) < 30.0 ng/ml…
Expand
2005
2005
Increased systemic efficacy of aphidicolin encapsulated in liposomes.
M. Michaelis
,
A. Zimmer
,
Nganou Handjou
,
J. Činátl
,
J. Cinatl
Oncology Report
2005
Corpus ID: 9611778
Aphidicolin, a tetracyclic diterpene antibiotic produced by Cephalosporium aphidicola, is under investigation as anti-cancer drug…
Expand
2004
2004
Activity of aphidicolin glycinate alone or in combination with cisplatin in a murine ovarian tumor resistant to cisplatin
G. Damia
,
G. Tagliabue
,
+4 authors
M. D’Incalci
Cancer Chemotherapy and Pharmacology
2004
Corpus ID: 22039353
SummaryAphidicolin, a reversible inhibitor of DNA polymerase α and δ, has recently been reported to reverse the resistance to…
Expand
1999
1999
Aphidicolin glycinate inhibits human neuroblastoma cell growth in vivo.
J. Činátl
,
J. Činátl
,
+9 authors
D. Schwabe
Oncology Report
1999
Corpus ID: 34718539
Aphidicolin is a fungal derived tetracyclic diterpene antibiotic. It is selectively toxic for neuroblastoma (NB) cells in vitro…
Expand
1995
1995
CRC/EORTC/NCI Joint Formulation Working Party: experiences in the formulation of investigational cytotoxic drugs.
J. Beijnen
,
KP Flora
,
GW Halbert
,
RE Henrar
,
J. Slack
British Journal of Cancer
1995
Corpus ID: 10091126
The pharmaceutical formulation of a new anti-tumour agent has often been perceived as the bottleneck in anti-cancer drug…
Expand
Highly Cited
1994
Highly Cited
1994
Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo.
P. O'dwyer
,
J. Moyer
,
+4 authors
J. Plowman
Cancer Research
1994
Corpus ID: 16446866
Aphidicolin, an inhibitor of DNA polymerases alpha and delta, is cytotoxic in vitro against tumor cells. The poor solubility of…
Expand
Highly Cited
1991
Highly Cited
1991
Phase I and clinical pharmacological evaluation of aphidicolin glycinate.
C. Sessa
,
M. Zucchetti
,
+7 authors
M. D’Incalci
Journal of the National Cancer Institute
1991
Corpus ID: 41518470
The toxicity profile and the pharmacokinetics of aphidicolin glycinate, a water-soluble analogue of aphidicolin, have been…
Expand
1991
1991
Lack of significant modulation of the formation and removal of platinum-DNA adducts by aphidicolin glycinate in two logarithmically-growing ovarian tumour cell lines in vitro.
W. Dempke
,
S. Shellard
,
A. Fichtinger-Schepman
,
B. Hill
Carcinogenesis
1991
Corpus ID: 38228069
Two recently established human ovarian carcinoma cell lines (JA-T and TR175) have been used to study the effects of aphidicolin…
Expand
1990
1990
The effect of DNA polymerase inhibitors on the cytotoxicity of cisplatin in human ovarian carcinoma cells.
E. Katz
,
P. Andrews
,
Stephen B. Howell
Cancer Communications
1990
Corpus ID: 23920575
We examined the effect of specific inhibitors of DNA polymerases alpha and delta, and beta, on cisplatin (DDP) cytotoxicity in…
Expand
1989
1989
A gas chromatographic mass spectrometric assay for the determination of aphidicolin in plasma of cancer patients.
S. Rotondo
,
M. Zucchetti
,
C. Sessa
,
M. D’Incalci
,
E. Benfenati
,
R. Fanelli
Journal of Pharmacy and Science
1989
Corpus ID: 22430402
A gas chromatographic-mass spectrometric (GC-MS) method is described for the determination of the novel anticancer agent…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE